Početna › KOPB
Kliničke studije za KOPB koje traže sudionike u SAD-u
98 studija za KOPB traži sudionike na lokacijama širom Sjedinjenih Američkih Država.
Gradovi s najviše studija
- Philadelphia, PA23 studija
- Miami, FL18 studija
- Birmingham, AL17 studija
- Boston, MA17 studija
- Houston, TX15 studija
- Orlando, FL15 studija
- Baltimore, MD14 studija
- Chicago, IL14 studija
- Dallas, TX12 studija
- Pittsburgh, PA12 studija
- New York City, NY11 studija
- Ann Arbor, MI10 studija
- Detroit, MI9 studija
- Winston-Salem, NC9 studija
- Los Angeles, CA9 studija
- Phoenix, AZ9 studija
- Charlotte, NC9 studija
- Kansas City, KS9 studija
- Hialeah, FL8 studija
- Newport Beach, CA8 studija
- Columbus, OH8 studija
- Cleveland, OH8 studija
- Tampa, FL7 studija
- Nashville, TN7 studija
- Durham, NC7 studija
- Kendall, FL7 studija
- Denver, CO7 studija
- Milwaukee, WI7 studija
- Jacksonville, FL6 studija
- West Palm Beach, FL6 studija
- Farmington Hills, MI6 studija
- Indianapolis, IN6 studija
- Aurora, CO6 studija
- St. Louis, MO5 studija
- El Paso, TX5 studija
- Las Vegas, NV5 studija
- Shreveport, LA5 studija
- Ocala, FL5 studija
- Savannah, GA5 studija
- Baton Rouge, LA5 studija
Po državama
- Alabama21 studija
- Arizona17 studija
- Colorado15 studija
- Connecticut3 studija
- Florida28 studija
- Georgia12 studija
- Idaho4 studija
- Illinois19 studija
- Indiana10 studija
- Iowa6 studija
- Kalifornija26 studija
- Kansas12 studija
- Kentucky5 studija
- Louisiana9 studija
- Maine3 studija
- Maryland16 studija
- Massachusetts25 studija
- Michigan22 studija
- Minnesota11 studija
- Mississippi3 studija
- Missouri7 studija
- Montana3 studija
- Nebraska5 studija
- Nevada8 studija
- New Jersey7 studija
- New York19 studija
- North Carolina22 studija
- Ohio17 studija
- Oklahoma8 studija
- Oregon6 studija
- Pennsylvania33 studija
- South Carolina14 studija
- South Dakota6 studija
- Tennessee14 studija
- Texas25 studija
- Utah6 studija
- Vermont5 studija
- Virginia12 studija
- Washington6 studija
- West Virginia5 studija
- Wisconsin8 studija
Nedavno ažurirane studije
Službeni tekst studije (engleski)
A Study Evaluating the Efficacy of Budesonide, Glycopyrronium and Formoterol Fumarate Metered Dosed Inhaler on Cardiopulmonary Outcomes in Chronic Obstructive Pulmonary Disease
U tijeku regrutacijaFaza 3
Od 40 do 80 godina · Oba spola · Ažurirano 2. lis 2026. · NCT06283966Evaluation of the Paramedic Evaluation for Acute COPD Exacerbation
U tijeku regrutacija
Od 40 godina i više · Oba spola · Ažurirano 2. lis 2026. · NCT07072039Efficacy, Safety, and Tolerability Study of Lunsekimig Compared With Placebo in Adult Participants With Inadequately Controlled Chronic Obstructive Pulmonary Disease (COPD), Characterized by an Eosinophilic Phenotype
U tijeku regrutacijaFaza 3
Od 40 do 80 godina · Oba spola · Ažurirano 1. lis 2026. · NCT07190222WIN Ratio Analysis to Determine a Strategy of Non- Invasive SUpport for Respiratory Failure in the EmeRgency Department
U tijeku regrutacija
Od 18 godina i više · Oba spola · Ažurirano 1. lis 2026. · NCT07558265To Evaluate the Effect of EXPD-101/FXS7553 Compared With Placebo in Patients With COPD Over 52 Weeks of Treatment
U tijeku regrutacijaFaza 2
Od 40 do 85 godina · Oba spola · Ažurirano 30. ruj 2026. · NCT07684820Mindful Steps 2.0: Promoting Physical Activity in Patients With COPD and HF
U tijeku regrutacija
Od 40 godina i više · Oba spola · Ažurirano 29. ruj 2026. · NCT05934565A Study of 24 to 52 Weeks Treatment to Evaluate The Efficacy And Safety of Galvokimig in Study Participants With Moderate-to-Severe Chronic Obstructive Pulmonary Disease (COPD) With Chronic Bronchitis
U tijeku regrutacijaFaza 2
Od 40 do 80 godina · Oba spola · Ažurirano 25. ruj 2026. · NCT07725939A Study to Investigate the Efficacy and Safety of GSK5784283 (Felcorekibart) Compared With Placebo in Participants With Moderate to Very Severe COPD (PERSIST COPD-2)
U tijeku regrutacijaFaza 3
Od 40 do 80 godina · Oba spola · Ažurirano 25. ruj 2026. · NCT07780656: Vascular Function in Health and Disease
U tijeku regrutacijaFaza 1Zdravi dobrovoljci dobrodošli
Od 18 godina i više · Oba spola · Ažurirano 25. ruj 2026. · NCT02966665A Study of Brenipatide (LY3537031) in Adult Participants With Moderate-to-Severe Chronic Obstructive Pulmonary Disease (COPD)
U tijeku regrutacijaFaza 2
Od 40 do 75 godina · Oba spola · Ažurirano 25. ruj 2026. · NCT07759245Efficacy, Safety, and Tolerability Study of Lunsekimig Compared With Placebo in Adult Participants With Inadequately Controlled Chronic Obstructive Pulmonary Disease (COPD) Characterized by an Eosinophilic Phenotype
U tijeku regrutacijaFaza 3
Od 40 do 80 godina · Oba spola · Ažurirano 22. ruj 2026. · NCT07190209A Study to Investigate Airway Inflammation With Dupilumab Subcutaneously in Participants Aged ≥40 to ≤85 Years With Chronic Obstructive Pulmonary Disease.
U tijeku regrutacijaFaza 4
Od 40 do 85 godina · Oba spola · Ažurirano 22. ruj 2026. · NCT07053423A Study to Evaluate the Long-term Safety and Efficacy of Lunsekimig in Adult Participants With Chronic Obstructive Pulmonary Disease (COPD)
U tijeku regrutacijaFaza 3
Od 40 do 80 godina · Oba spola · Ažurirano 21. ruj 2026. · NCT07793409An Evaluation of the AeriSeal System for CONVERTing Collateral Ventilation Status in Patients With Severe Emphysema
U tijeku regrutacija
Od 40 do 80 godina · Oba spola · Ažurirano 17. ruj 2026. · NCT06035120A Study of WIN378 in Participants With Moderate to Severe COPD (Sirius)
U tijeku regrutacijaFaza 2
Od 40 do 80 godina · Oba spola · Ažurirano 15. ruj 2026. · NCT07646587Nebulizer Versus Handheld Maintenance Therapy for Patients With COPD
U tijeku regrutacijaFaza 4
Od 60 godina i više · Oba spola · Ažurirano 14. ruj 2026. · NCT07816835A Study to Investigate the Efficacy and Safety of GSK5784283 (Felcorekibart) Compared With Placebo in Participants With Moderate to Very Severe COPD (PERSIST COPD-1)
U tijeku regrutacijaFaza 3
Od 40 do 80 godina · Oba spola · Ažurirano 9. ruj 2026. · NCT07780669A Study to Investigate the Effect of AZD6793 in Participants With Moderate to Very Severe Chronic Obstructive Pulmonary Disease
U tijeku regrutacijaFaza 2
Od 40 godina i više · Oba spola · Ažurirano 9. ruj 2026. · NCT07082738Clinical Trial of Omalizumab for Allergen Sensitized and Exposed Individuals With COPD
U tijeku regrutacijaFaza 2
Od 40 godina i više · Oba spola · Ažurirano 4. ruj 2026. · NCT07059091A Study to Investigate the Efficacy and Safety of Tezepelumab in Adult Participants With Moderate to Very Severe COPD (D5241C00007)
U tijeku regrutacijaFaza 3
Od 40 do 80 godina · Oba spola · Ažurirano 3. ruj 2026. · NCT06878261A Study to Investigate the Efficacy and Safety of Tezepelumab in Adult Participants With Moderate to Very Severe COPD (D5241C00006)
U tijeku regrutacijaFaza 3
Od 40 do 80 godina · Oba spola · Ažurirano 3. ruj 2026. · NCT06883305A Study to Test the Safety and Effects of Inhaled GDC-6988 in Participants With Muco-obstructive Disease
U tijeku regrutacijaFaza 1
Od 18 godina i više · Oba spola · Ažurirano 2. ruj 2026. · NCT06603246COPD Exacerbation Follow Up
U tijeku regrutacijaOpažajna studija
Od 40 godina i više · Oba spola · Ažurirano 2. ruj 2026. · NCT07118306The Study of Chronic Obstructive Pulmonary Disease (COPD) Participants Treated With Dupilumab (STRIDE) Registry
U tijeku regrutacijaOpažajna studija
Od 40 godina i više · Oba spola · Ažurirano 1. ruj 2026. · NCT07612878A Study to Learn About the Study Medicine Called PF-07275315 in People With Moderate to Severe Chronic Obstructive Pulmonary Disease
U tijeku regrutacijaFaza 2/3
Od 35 do 80 godina · Oba spola · Ažurirano 31. kol 2026. · NCT07363694Iz ClinicalTrials.gov, podaci preuzeti 4. lis 2026.. Svaka studija ima svoje uvjete prihoda; tim studije odlučuje tko se može priključiti.